Ann Avron

986 total citations
8 papers, 678 citations indexed

About

Ann Avron is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Ann Avron has authored 8 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in Ann Avron's work include Diabetes and associated disorders (4 papers), Pancreatic function and diabetes (3 papers) and Protease and Inhibitor Mechanisms (2 papers). Ann Avron is often cited by papers focused on Diabetes and associated disorders (4 papers), Pancreatic function and diabetes (3 papers) and Protease and Inhibitor Mechanisms (2 papers). Ann Avron collaborates with scholars based in Israel, United States and United Kingdom. Ann Avron's co-authors include Merana Tamir, Dana Elias, Itamar Raz, Irun R. Cohen, Muriel Metzger, Ruth Gallily, Ζ. Josefsberg, Naomi Weintrob, Moshe Phillip and Liora Lazar and has published in prestigious journals such as The Lancet, The Journal of Immunology and FEBS Letters.

In The Last Decade

Ann Avron

8 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Avron Israel 8 382 316 307 203 165 8 678
Isabelle Bergerot France 12 464 1.2× 273 0.9× 221 0.7× 457 2.3× 156 0.9× 14 866
Gene Barbour United States 13 841 2.2× 560 1.8× 422 1.4× 518 2.6× 143 0.9× 15 1.2k
Susan Eastman United States 13 173 0.5× 113 0.4× 78 0.3× 386 1.9× 88 0.5× 16 539
Bryan Coon United States 13 453 1.2× 217 0.7× 166 0.5× 566 2.8× 93 0.6× 15 901
Shoshana Israel Israel 12 137 0.4× 44 0.1× 117 0.4× 108 0.5× 228 1.4× 29 488
Serge Durviaux Belgium 10 312 0.8× 339 1.1× 132 0.4× 27 0.1× 384 2.3× 13 703
Brenda Kahan United States 14 220 0.6× 200 0.6× 50 0.2× 26 0.1× 525 3.2× 21 707
Seung-il Shin United States 14 150 0.4× 75 0.2× 80 0.3× 52 0.3× 251 1.5× 24 508
Lisa Schubert United States 11 134 0.4× 35 0.1× 43 0.1× 785 3.9× 323 2.0× 14 1.1k
Jenny Aurielle B. Babon United States 9 150 0.4× 122 0.4× 93 0.3× 251 1.2× 196 1.2× 12 587

Countries citing papers authored by Ann Avron

Since Specialization
Citations

This map shows the geographic impact of Ann Avron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Avron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Avron more than expected).

Fields of papers citing papers by Ann Avron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Avron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Avron. The network helps show where Ann Avron may publish in the future.

Co-authorship network of co-authors of Ann Avron

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Avron. A scholar is included among the top collaborators of Ann Avron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Avron. Ann Avron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Elias, Dana, Ann Avron, Merana Tamir, & Itamar Raz. (2006). DiaPep277® Preserves Endogenous Insulin Production by Immunomodulation in Type 1 Diabetes. Annals of the New York Academy of Sciences. 1079(1). 340–344. 19 indexed citations
2.
Raz, Itamar, Ann Avron, Merana Tamir, et al.. (2006). Treatment of new‐onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial. Diabetes/Metabolism Research and Reviews. 23(4). 292–298. 78 indexed citations
3.
Lazar, Liora, Naomi Weintrob, Ann Avron, et al.. (2006). Heat‐shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double‐blind phase II study. Diabetes/Metabolism Research and Reviews. 23(4). 286–291. 84 indexed citations
4.
Raz, Itamar, Dana Elias, Ann Avron, et al.. (2001). β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. The Lancet. 358(9295). 1749–1753. 381 indexed citations
5.
Ariel, Amiram, Rami Hershkoviz, Ann Avron, et al.. (1998). IL-2 Induces T Cell Adherence to Extracellular Matrix: Inhibition of Adherence and Migration by IL-2 Peptides Generated by Leukocyte Elastase. The Journal of Immunology. 161(5). 2465–2472. 65 indexed citations
6.
Avron, Ann & Ruth Gallily. (1995). Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages. Journal of Leukocyte Biology. 57(2). 264–268. 24 indexed citations
7.
Avron, Ann, et al.. (1991). Effect of alanine insertion (P′5) on the reactive centre of α1‐antitrypsin. FEBS Letters. 280(1). 41–43. 10 indexed citations
8.
Kloog, Yoel, Michal Horowitz, Uri Meiri, Ronit Galron, & Ann Avron. (1985). Regulation of submaxillary gland muscarinic receptors during heat acclimation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 845(3). 428–435. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026